Molecular and Clinical Follow-Up after Treatment of Multiple Myeloma

Publisher： Karger

E-ISSN： 1421-9662|112|1-2|105-110

ISSN： 0001-5792

Source： Acta Haematologica, Vol.112, Iss.1-2, 2004-06, pp. : 105-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patient Management and Clinical Follow‐Up After Cardiomyoplasty

By  

JOURNAL OF CARDIAC SURGERY (ELECTRONIC), Vol. 6, Iss. 1S, 1991-03 ,pp. : 89-99

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5‐year follow‐up

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 3, 2015-11 ,pp. : 344-354

John Wiley & Sons Inc

Access to resources Recommend Favorite

One‐year follow‐up of a TRASER clinical trial for the treatment of nasal telangiectasias

By  

LASERS IN SURGERY AND MEDICINE, Vol. 50, Iss. 1, 2018-01 ,pp. : 61-63

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optic Pathway Gliomas: Clinical Manifestation, Treatment, and Follow-Up

By  

Pediatric Neurosurgery, Vol. 51, Iss. 5, 2016-04 ,pp. : 223-228

Karger

Access to resources Recommend Favorite

What is the value of routine follow-up after diagnosis and treatment of cancer?

By Rose Peter W   Watson Eila  

British Journal of General Practice, Vol. 59, Iss. 564, 2009-07 ,pp. : 482-483

Royal College of General Practitioners

Access to resources Recommend Favorite